Indoco Remedies Limited (NSE:INDOCO)
India · Delayed Price · Currency is INR 227.60
+8.09 (3.69%)
Nov 12, 2026, 3:29 PM IST
Indoco Remedies Market Cap
Indoco Remedies has a market cap or net worth of 21.01 billion as of November 12, 2026. It is the 20,062nd most valuable company in the world and the 1,260th biggest in India. Its market cap has decreased by 15.42% in one year.
Market Cap
21.01B
Enterprise Value
31.02B
Revenue
19.09B
Global Rank
Country Rank
#1,260 India
PE Ratio
66.48
ChartMarket Cap Chart
Since January 14, 2005, Indoco Remedies's market cap has increased from 4.66B to 21.01B, an increase of 350.82%. That is a compound annual growth rate of 7.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 21.01B | -2.93% |
| Dec 31, 2025 | 21.64B | -29.33% |
| Dec 31, 2024 | 30.62B | -15.91% |
| Dec 29, 2023 | 36.42B | -2.82% |
| Dec 30, 2022 | 37.47B | -10.49% |
| Dec 31, 2021 | 41.86B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 51.80B |
| RPG Life Sciences | 43.08B |
| Solara Active Pharma Sciences | 32.12B |
| Ind-Swift Laboratories | 31.48B |
| Sakar Healthcare | 23.81B |
| Windlas Biotech | 20.67B |
| Beta Drugs | 19.07B |
| Jagsonpal Pharmaceuticals | 14.38B |